AI evidence summary · MVP
Vitamin A for Measles Mortality Children
AI research summary · not rated
Research results
Findings are currently provided in Traditional Chinese; source excerpts retain their original language.
Retrieval is incomplete. These results do not represent all relevant research.
Research finding 1
two treatment days; mortality follow-up time not reported麻疹兒童接受兩劑各 200,000 IU 維生素 A,相較安慰劑加標準治療,全因死亡風險降低 64%(RR=0.36)。
短引文的 95% 信賴區間在數值前截斷,不能補齊;來源納入水劑型與油劑型製劑,且未報告死亡追蹤時間。
Scope relevant to this question: Direct randomized-trial evidence in children with measles receiving two 200,000 IU doses of vitamin A versus placebo plus standard treatment; the source includes both water-based and oil-based preparations.
- Population
- children with measles
- Intervention
- vitamin A, two doses
- Comparator
- placebo plus standard treatment
- Outcome
- all-cause mortality
- Follow-up
- two treatment days; mortality follow-up time not reported
- Formulation
- water-based or oil-based vitamin A
- Dose
- 200,000 IU on each of two days
Source excerpt: There was a 64% reduction in the risk of mortality in children who were given two doses of 200,000 IU of vitamin A (RR=0.36; 95%View source
Research finding 2
mortality follow-up time not reported在麻疹兒童中,單次 200,000 IU 維生素 A 加標準治療,相較於安慰劑加標準治療,全因死亡風險比為 0.77(95% 信賴區間 0.34–1.78)。
估計範圍同時包含死亡風險下降、沒有差異及上升,無法據此確定效果;來源未報告死亡追蹤時間。
Relevant to the question; some study details remain unknown. Direct randomized-trial evidence in children with measles, but this estimate applies only to a single 200,000 IU dose; mortality follow-up time was not reported.
- Population
- children with measles
- Intervention
- single-dose vitamin A plus standard treatment
- Comparator
- placebo plus standard treatment
- Outcome
- all-cause mortality
- Follow-up
- mortality follow-up time not reported
- Formulation
- Not established
- Dose
- single dose of 200,000 IU
No additional short excerpt is shown for this finding. See the linked source to check the result.
View sourceResearch finding 3
mortality follow-up time not reported以隨機效應模型合併所有研究時,確診麻疹兒童接受維生素 A 加標準治療,相較安慰劑加標準治療,全因死亡風險未顯著降低。
合併估計整合了不同維生素 A 療程;來源未提供此短引文的效果量與死亡追蹤時間。
Relevant to the question; some study details remain unknown. Direct randomized-trial evidence in children with diagnosed measles receiving vitamin A after diagnosis versus placebo plus standard treatment; the pooled estimate combines the studied regimens.
- Population
- children with diagnosed measles
- Intervention
- vitamin A therapy plus standard treatment
- Comparator
- placebo plus standard treatment
- Outcome
- all-cause mortality
- Follow-up
- mortality follow-up time not reported
- Formulation
- Not established
- Dose
- various regimens pooled
Source excerpt: There was no significant reduction in the risk of mortality in the vitamin A group when all the studies were pooled using the random-effects modelView source
What remains unknown
- 此安全性估計涉及 6 個月至 5 歲、表面健康且居住於社區的兒童接受預防性補充;研究排除了目前患病(包括麻疹)與住院的兒童,因此無法直接套用於麻疹治療。
Sources consulted
- Vitamin A for treating measles in children. Abstract only · 2026-09-09T16:30:55.890717Z
- Vitamin A for treating measles in children. Abstract only · 2026-09-09T16:30:55.890717Z
Reading and assessment notes
This AI research summary has not been assigned an overall grade. Learn how summaries and ratings differ.
Absence of reported harms does not establish safety. This summary does not provide individual treatment or dosing advice.
Data and assessment record
Processing record
Search or processing incomplete
Sources through:2026-09-09 · Generated:2026-09-10T03:31:47.340123Z
Retrieved 14 records · Screened 14 · Included 2 reports · Omitted 0
Run:pilot-r6-20260909T163050Z
codex_cli / gpt-5.6-sol / automated-mvp-live-v1
{
"included": 2,
"limits_hit": [
"fulltexts",
"llm_source_payload"
],
"omitted": 0,
"retrieved": 14,
"screened": 14
} sha256:75ee2e0346fd39524ef45ea9bc6a11cdc36895888dac5aad95cbe24b3dcca10d